News | July 31, 2022
Torrent Pharmaceuticals posts Q1FY23 consolidated PAT Rs. 354 Cr
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
Torrent Pharmaceuticals has reported total income of Rs. 2377 crores during the period ended June 30, 2022.
The integration and transition of the brands are expected to be completed by June 2022.
Torrent Pharmaceuticals has reported consolidated financial results for the period ended December 31, 2021.
DCGI approved the drug based on the review of clinical data
Torrent Pharmaceuticals Limited has reported consolidated financial results for the period ended September 30, 2021
Torrent is one of India's fastest-growing pharma majors
The company posted net profit of Rs.321 crores for the period ended June 30, 2020.
The agreement will help ensure wider reach and access to patients in India
He has previously served in pivotal HR leadership roles at RPG Life Sciences, Akumentis Healthcare, and Wockhardt
The NPPA has capped prices for 41 drug combinations including diabetes, cholesterol, and sleep disorder treatments
Subscribe To Our Newsletter & Stay Updated
